Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alexander Macdonald is active.

Publication


Featured researches published by Alexander Macdonald.


Journal of Chromatography A | 1973

Small-volume solid-elcetrode flow-through electrochemical cells : Preliminary evaluation using pulse polarographic techniques

Alexander Macdonald; Paul D. Duke

Abstract A preliminary evaluation is given of the use of potentiostatic pulse polarographic techniques for solid-electrode flow-through electrochemical cells as detectors for use in both automated analysis and liquid chromatography. The following advanatages are noted over previously reported constant-applied-potential techniques: increased sensitivity, minimal effect of flow-rate on current measurement and a vast increase in electrode stability for the short-term sampling period and for extended routing operation.


Bioorganic & Medicinal Chemistry Letters | 2010

Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

Patrizio Mattei; Markus Boehringer; Patrick Di Giorgio; Holger Fischer; Michael Hennig; Joerg Huwyler; Buelent Kocer; Bernd Kuhn; Bernd Michael Loeffler; Alexander Macdonald; Robert Narquizian; Etienne Rauber; Elena Sebokova; Urs Sprecher

Design, synthesis, and SAR are described for a class of DPP-IV inhibitors based on aminobenzo[a]quinolizines with non-aromatic substituents in the S1 specificity pocket. One representative thereof, carmegliptin (8p), was chosen for clinical development. Its X-ray structure in complex with the enzyme and early efficacy data in animal models of type 2 diabetes are also presented.


Archive | 1969

1-METHYL-2-SUBSTITUTED 5-NITROIMIDAZOLES

Max Hoffer; Alexander Macdonald


Archive | 2006

Modified release compositions for DPP-IV inhibitors

Bernd Michael Loeffler; Alexander Macdonald; Cynthia Rocha; Eric Worth


Drug Metabolism Reviews | 1995

Identifying the “Residue of Toxicological. Concern”— Bioavailability and Bioactivity Testing

Alexander Macdonald


Archive | 2006

Composition pharmaceutique comprenant un inhibiteur de la dpp-iv

Bernd Michael Loeffler; Alexander Macdonald; Cynthia Rocha; Eric Worth


Archive | 2006

Pharmaceutical composition comprising a dpp-iv inhibitor

Bernd Michael Loeffler; Alexander Macdonald; Cynthia Rocha; Eric Worth


Archive | 2006

Pharmazeutische zusammensetzung mit einem dpp-iv-hemmer

Bernd Michael Loeffler; Alexander Macdonald; Cynthia Rocha; Eric Worth


Drug Metabolism Reviews | 1990

Overview on Bound Residue Issues: Introduction

Alexander Macdonald


Drug Metabolism Reviews | 1990

Adjournment and Symposium Summary Statement

Alexander Macdonald

Collaboration


Dive into the Alexander Macdonald's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge